Breast Tumor
Showing 26 - 50 of >10,000
HER2-positive Advanced Breast Cancer Patients Treated With ADC
Recruiting
- Breast Cancer
- HER2 expression of circulating tumor cells
-
Beijing, Beijing, ChinaThe Fifth Medical Center of PLA General Hospital
Apr 18, 2023
HER2-low Advanced Breast Cancer Patients Treated With ADC
Recruiting
- Breast Cancer
- HER2 expression of circulating tumor cells
-
Beijing, Beijing, ChinaThe Fifth Medical Center of PLA General Hospital
Apr 18, 2023
Breast Cancer Undergoing Neoadjuvant Therapy
Recruiting
- Stage I-III Breast Cancer
-
Hangzhou, China2nd Affiliated Hospital, School of Medicine, Zhejiang University
Dec 13, 2022
Breast Cancer Stage III Trial in Seoul (Whole breast / chest wall & regional lymph node irradiation, Internal mammary or
Recruiting
- Breast Cancer Stage III
- Whole breast / chest wall & regional lymph node irradiation
- Internal mammary or supraclavicular lymph node boost
-
Seoul, Korea, Republic ofSamsung Medical Center
Jun 8, 2023
Multiparametric MRI asNon-Invasive Biomarker of Tumor
Recruiting
- Breast Cancer
- Triple-negative Breast Cancer
- Tempus assay
- +2 more
-
Nashville, TennesseeVanderbilt University Medical Center
Jan 10, 2023
Tumor, Brain, Tumor, Breast, Tumor Skin Trial
Not yet recruiting
- Tumor, Brain
- +2 more
- (no location specified)
Jan 9, 2023
Breast Cancer Stage II, Breast Cancer Stage III, Solid Tumor Trial in Wuxi ([18F]SF-DEVD-2, [18F]-FDG)
Recruiting
- Breast Cancer Stage II
- +2 more
-
Wuxi, Jiangsu, ChinaAffiliated Hospital of Jiangnan University
Apr 22, 2023
Tumor-Derived FGF19
Recruiting
- Colorectal Cancer
- +2 more
-
Orlando, FloridaBurnett School Biomedical Sciences
Sep 28, 2023
Breast Cancer, Axillary Nodal Disease, Female Breast Cancer Trial (Breast Surgery (BCS or mastectomy) with TAD/SNB, Adjuvant
Not yet recruiting
- Breast Cancer
- +5 more
- Breast Surgery (BCS or mastectomy) with TAD/SNB
- Adjuvant Radiation Therapy
- (no location specified)
Oct 24, 2023
Circulating Tumor Cells (CTCs) in Metastatic Breast Cancer (MBC)
Recruiting
- Metastatic Breast Cancer
- CellSearch Circulating Tumor Cells
-
Rochester, Minnesota
- +1 more
Dec 21, 2022
Metastatic Breast Cancer, Tumor, Muscle Tumors Trial in Colorado Springs (Method(s)1 Attribution, Method(s)2 Attribution,)
Not yet recruiting
- Metastatic Breast Cancer
- +3 more
- Method(s)1 Attribution
- Method(s)2 Attribution,
-
Colorado Springs, ColoradoPNAF Medical
Nov 23, 2023
Advanced Breast Cancer, Advanced Lung Cancer Trial (Tumor-infiltrating lymphocytes, IL-2)
Not yet recruiting
- Advanced Breast Cancer
- Advanced Lung Cancer
- Tumor-infiltrating lymphocytes
- IL-2
- (no location specified)
Oct 26, 2023
Breast Tumors Trial in Beijing (Preoperative MRI-guided tumor-bed boost and postopreative ultra-hypofractionated radiotherapy
Recruiting
- Breast Neoplasms
- Preoperative MRI-guided tumor-bed boost and postopreative ultra-hypofractionated radiotherapy (26 Gy/5.2Gy/5)
-
Beijing, Beijing, ChinaNational Cancer Center/National Clinical Research Center for Can
Nov 1, 2022
HER2-positive Breast Cancer, Metastatic Cancer, Metastatic Breast Cancer Trial in Chicago, Minneapolis (ALX148, Fam-Trastuzumab
Recruiting
- HER2-positive Breast Cancer
- +17 more
- ALX148
- Fam-Trastuzumab Deruxtecan-Nxki
-
Chicago, Illinois
- +1 more
May 19, 2023
Circulating Tumor DNA and Immunophenotyping as Potential
Recruiting
- Breast Cancer
-
Rochester, MinnesotaMayo Clinic in Rochester
Nov 7, 2022
Triple Negative Breast Cancer, Neoadjuvant Chemo, Pembrolizumab Trial in Seoul (Visium, Whole Genome Sequencing(WGS)/Whole
Recruiting
- Triple Negative Breast Cancer
- +3 more
- Visium, Whole Genome Sequencing(WGS)/Whole Transcriptome Sequencing(WTS)
-
Seoul, Korea, Republic ofSamsung Medical Center
Jun 15, 2023
Ultrasound Trial in Beijing
Recruiting
- Ultrasound
-
Beijing, Beijing, ChinaChinese PLA General Hospital
Aug 17, 2021
Metastatic Breast Cancer, Advanced Non-Small Cell Squamous Lung Cancer, Solid Tumor, Adult Trial (Patritumab deruxtecan)
Not yet recruiting
- Metastatic Breast Cancer
- +2 more
- Patritumab deruxtecan
- (no location specified)
May 9, 2023
Breast Cancer, Lipid Cell; Tumor, Nutrition Related Cancer Trial in Roma (Lipidomic analysis for breast cancer patients)
Not yet recruiting
- Breast Cancer
- +3 more
- Lipidomic analysis for breast cancer patients
-
Roma, ItalyFondazione Policlinico Universitario A. Gemelli IRCCS
Sep 4, 2023
Triple-negative Breast Cancer Trial (Pembrolizumab 25 mg/ml, Paclitaxel injection)
Not yet recruiting
- Triple-negative Breast Cancer
- Pembrolizumab 25 mg/ml
- Paclitaxel injection
- (no location specified)
Oct 11, 2023
Circulating Tumor DNA (ctDNA) in Late-stage Breast Cancer
Completed
- Metastatic Breast Cancer
- +2 more
- ctDNA testing
- (no location specified)
Jun 16, 2022
Comparison of the Breast Tumor Microenvironment
Recruiting
- Triple Negative Breast Cancer
- Hormone Receptor Positive Malignant Neoplasm of Breast
- Breast tissue collection
- Blood sample collection
-
New York, New YorkColumbia University Irving Medical Center
Aug 18, 2021
Metastatic Cancer, Breast Cancer, Lobular Breast Carcinoma Trial in Madison (18F-fluorofuranylnorprogesterone, Liquid Biopsy,
Recruiting
- Metastatic Cancer
- +2 more
- 18F-fluorofuranylnorprogesterone
- +2 more
-
Madison, WisconsinUW Carbone Cancer Center
Oct 10, 2023
Breast Tumor Trial in Rochester (GE Logiq E10 clinical ultrasound scanner, Verasonics research scanner)
Recruiting
- Breast Tumor
- GE Logiq E10 clinical ultrasound scanner
- Verasonics research scanner
-
Rochester, MinnesotaMayo Clinic in Rochester
Dec 23, 2021